About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Clinical Psychopharmacology
›
Top Articles
Journal of Clinical Psychopharmacology
Psychiatry
,
Pharmacology
1.7
(top 10%)
Impact Factor
1.9
(top 10%)
extended IF
121
(top 3%)
H-Index
1.7K
authors
6.2K
papers
133.2K
citations
4.9K
citing journals
30.1K
citing authors
Most Cited Articles of Journal of Clinical Psychopharmacology
Title
Year
Citations
Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam
1990
532
A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients
1993
512
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
1997
488
Effects of SSRIs on sexual function: a critical review
1999
478
Validity and Reliability of the Observer??s
1990
403
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease
2008
390
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder
2008
384
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)
2006
375
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis
2009
353
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study
2008
335
Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database
2002
327
The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV
1996
324
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system
2002
317
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
2000
316
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline
1998
273
Treatment of social phobia with gabapentin: a placebo-controlled study
1999
267
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder
2004
263
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
2004
257
Modifications of the Serotonin System by Antidepressant Treatments
1987
255
The status of disulfiram: a half of a century later
2006
254
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio
2001
253
Psychological and pharmacological treatments of social phobia: a meta-analysis
2001
249
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
2000
249
Buprenorphine treatment of refractory depression
1995
247
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression
1990
242
previous
2008
2009
2010
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.